Format

Send to

Choose Destination
See comment in PubMed Commons below
BMC Med Res Methodol. 2003 Oct 27;3:22.

How many repeated measures in repeated measures designs? Statistical issues for comparative trials.

Author information

1
Integrative Medicine Service, Biostatistics Service, Memorial Sloan Kettering Cancer Center, Howard 13, 1275 York Avenue NY, NY 10021, USA. vickersa@mskcc.org

Abstract

BACKGROUND:

In many randomized and non-randomized comparative trials, researchers measure a continuous endpoint repeatedly in order to decrease intra-patient variability and thus increase statistical power. There has been little guidance in the literature as to selecting the optimal number of repeated measures.

METHODS:

The degree to which adding a further measure increases statistical power can be derived from simple formulae. This "marginal benefit" can be used to inform the optimal number of repeat assessments.

RESULTS:

Although repeating assessments can have dramatic effects on power, marginal benefit of an additional measure rapidly decreases as the number of measures rises. There is little value in increasing the number of either baseline or post-treatment assessments beyond four, or seven where baseline assessments are taken. An exception is when correlations between measures are low, for instance, episodic conditions such as headache.

CONCLUSIONS:

The proposed method offers a rational basis for determining the number of repeat measures in repeat measures designs.

PMID:
14580266
PMCID:
PMC280679
DOI:
10.1186/1471-2288-3-22
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Support Center